Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
antiviral agents
asymptomatic
compliance
complications
highly active antiretroviral therapy
human immunodeficiency virus type 1
human immunodeficiency virus type 1, prophylaxis
preexposure prophylaxis
prevention of neurologic disorders
safety
sexually transmitted disease
treatment of neurologic disorder
viral infection
Showing articles 1050 to 1100 of 3092 << Previous Next >>

Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005

The Frequency of Intractable Seizures After Stopping AEDs in Seizure-Free Children With Epilepsy
Neurol 64:973-975, Camfield,P & Camfield,C., 2005

Neuropsychological Effects of Exposure to Anticonvulsant Medication in Utero
Neurol 64:949-954, 938, Vinten,J., et al, 2005

Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 36:916-921, Adams,H.,et al, 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005

Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005

Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005

Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in New Users of Antiepileptics
Neurol 64:1134-1138, Mockenhaupt,M.,et al, 2005

Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005

Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005

Acupuncture for Patients with Migraine
JAMA 293:2118-2125, Linde,K.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

The Ketogenic Diet
Neurologist 11:161-170, Sinha,S.R. &Kossof,E.H., 2005

The Neurologist and Patient Safety
Neurologist 11:140-149, Glick,T.H., 2005

Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005

Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005

Respiratory Adverse Events Associated with Diazepam Rectal Gel
Neurol 64:1768-1770, Pellock,J.M. &Shinnar,S., 2005

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005

New OnsetGeriatric Epilepsy, A Randomized Study of Gabapentin, Lamotrigine, and Carbamazepine
Neurol 64:1868-1873,1834, Rowan,A.J.,et al, 2005

Antiepileptic Drug Use of Women with Epilepsy and Congenital Malformations in Offspring
Neurol 64:1874-1878, Artama,M.,et al, 2005

Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005

Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005

Four-Year Outcome after Early Withdrawal of Antiepileptic Drugs in Childhood Epilepsy
Neurol 64:2136-2138, Geerts,A.T.,et al, 2005

Cognitive and Behavioral Effects of Lamotrigine and Topiramate in Healthy Volunteers
Neurol 64:2108-2114, Meador,K.J.,et al, 2005

Influenza Vaccination is Associated with a Reduced Risk of Stroke
Stroke 36:1501-1506, Grau,A.J.,et al, 2005

A Simple Score (ABCD) to Identify Individuals at High Early Risk of Stroke After Transient Ischaemic Attack
Lancet 366:29-36, Rothwell,P.M.,et al, 2005

Life-Threatening Acute Pancreatitis Associated with Interferon Beta-1a Treatment in Multiple Sclerosis
Neurol 65:170-171, Midgard,R.,et al, 2005

Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005

Follow-Up of 89 Asymptomatic Patients with Adrenoleukodystrophy Treated with Lorenzos Oil
Arch Neurol 62:1073-1080,1045, Moser,H.W.,et al, 2005

A Single Dose of Gabapentin Reduces Acute Pain and Allodynia in Patients with Herpes Zoster
Neurol 65:444-447,349, Berry,J.D. &Peterson,K.L., 2005

Polyneuropathy Associated with Interferon Beta Treatment in Patients with Multiple Sclerosis
Neurol 65:456-458, Ekstein,D.,et al, 2005

Calcium Antagnosits in Aneurysmal Subarachnoid Hemorrhage
Stroke 36:1816-1817, Rinkel,G.J.E.,et al, 2005

Safety and Efficacy of Buccal Midazolam Versus Rectal Diazepam for Emergency Treatment of Seizures in Children: A Randomised Controlled Trial
Lancet 366:205-210,182, McIntyre,J.,et al, 2005

Clinical Features of Status Epilepticus in Patients with HIV Infection
Neurol 65:314-316, Lee,K.C.,et al, 2005

Association of the Metabolic Syndrome with Intracranial Atherosclerotic Stroke
Neurol 65:296-298,188, Bang,O.Y.,et al, 2005

Lipid-Lowering Agent Use at Ischemic Stroke Onset is Associated with Decreased Mortality
Neurol 65:253-258, Elkind,M.S.V.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

West Nile Virus Among Blood Donors in the United States, 2003 and 2004
NEJM 353:451-459,516, Stramer,S.L.,et al, 2005

Propofol and Thiopental for Refractory Status Epilepticus in Children
Neurol 65:591-592,506, van Gestel,J.P.J.,et al, 2005

Improved Tolerability and Efficacy in Epilepsy Patients with Extended-Release Carbamazepine
Neurol 65:593-595, Ficker,D.M.,et al, 2005

Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Stroke 36:1881-1885, Feldmann,E.,et al, 2005

Aggregate Analysis of the Literature for Unruptured Intracranial Aneurysm Treatment
AJNR 26:1902-1908, Lee,T.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Use of Complementary and Alternative Therapies in Epilepsy, Cause for Concern
Arch Neurol 62:1472-1475, Pearl,P.L.,et al, 2005

Role for Complementary and Alternative Treatments in Epilepsy
Arch Neurol 62:1471-1472,1475, Scheller,J., 2005



Showing articles 1050 to 1100 of 3092 << Previous Next >>